CanadaIndustry

Shares in Canadian Cannabis Company Fall 28% Following Short-Sellers’ Report

Published on December 4, 2018 · Last updated July 28, 2020
aphria Short-Sellers
aphria/Facebook

LEAMINGTON, ONTARIO (CP) — Aphria Inc. says it stands behind its Latin American operations as its shares continued to fall in the wake of a short-sellers’ report that raised questions about the company’s acquisitions in the region.Learn About Cannabis in CanadaAphria chief executive Vic Neufeld said Tuesday the acquisition of licenses and other assets and related businesses in Colombia, Argentina and Jamaica and a right of first offer and refusal in respect of Brazil were an important strategic deal.

Neufeld said the company has made considerable progress supporting and building out its operations on the ground in Latin America and the Caribbean since the deal closed in September.

Together with other members of the company’s executive team, Neufeld said they personally bought a total of more than $3.1 million in Aphria shares on Monday as a demonstration of confidence in the company.

“It is the commitment of our incredible team and partners that has gotten us to where we are today, making Aphria a global cannabis success story,” Neufeld said.

Shares in Aphria fell nearly 28% in trading Monday after short sellers called the Canadian marijuana producer a “black hole” and alleged that its recent international acquisitions totalling roughly $280-million were “largely worthless.”

The shares were down an additional 17% or $1.32 at $6.28 in early trading Tuesday.

Quintessential Capital Management and Hindenburg Research, which are short on Aphria, alleged the company acquired foreign companies in countries including Jamaica, Argentina and Colombia at “vastly inflated” prices and in ways that it believes benefit a group of insiders.

Aphria, one of the largest Canadian cannabis companies by market capitalization, has called the short-sellers’ allegations “false and defamatory.”

Shop highly rated dispensaries near you

Showing you dispensaries near
See all dispensaries
The Canadian Press
The Canadian Press
The CP is one of the world's largest and most trusted sources of independent newsgathering.
View The Canadian Press's articles
Get good reads, local deals, and strain spotlights delivered right to your inbox.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.



Stay In Touch

Receive updates on new products, special offers, and industry news.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.

Leafly mobile app
Get high for less.
Download the Leafly app.
Download Leafly: Marijuana Reviews on the App Store
Download Leafly Marijuana Reviews on Google Play




* Statements made on this website have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. Information provided by this website or this company is not a substitute for individual medical advice.


© 2024 Leafly, LLC
Leafly and the Leafly logo are registered trademarks of Leafly, LLC. All Rights Reserved.